v3.25.0.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Revenues:      
Total revenues $ 59,345 $ 70,143 $ 138,590
Costs and operating expenses:      
Cost of product revenue 16,288 12,809 38,033
Research and development 46,263 58,885 80,099
Selling, general and administrative 55,148 53,250 52,172
Restructuring charges 0 3,284 3,167
Asset impairment and other charges 165 9,984 0
Total costs and operating expenses 117,864 138,212 173,471
Loss from operations (58,519) (68,069) (34,881)
Interest income 3,670 4,172 1,441
Interest and other expense, net ($0, $0 and $208 from a related party) (10,393) (12,274) 124
Loss before income taxes (65,242) (76,171) (33,316)
Provision for income taxes 34 69 276
Net loss $ (65,276) $ (76,240) $ (33,592)
Net loss per share, basic (in dollars per share) $ (0.89) $ (1.12) $ (0.51)
Net loss per share, diluted (in dollars per share) $ (0.89) $ (1.12) $ (0.51)
Weighted average common stock shares used in computing net loss per share, basic (in shares) 73,408 68,131 65,344
Weighted average common stock shares used in computing net loss per share, diluted (in shares) 73,408 68,131 65,344
Product revenue ($0, $0 and $514 from a related party)      
Revenues:      
Total revenues $ 36,786 $ 42,906 $ 116,676
Research and development revenue ($0, $0 and $1,245 from a related party)      
Revenues:      
Total revenues $ 22,559 $ 27,237 $ 21,914

Source